Is Pacific Edge (NZSE:PEB) In A Good Position To Invest In Growth?
Nov 15
Have your own idea? Try our Stock Screener
New Zealand (NZX) Biotech Industry Analysis
UpdatedNov 25, 2024
DataAggregated Company Financials
Companies1
- 7D12.0%
- 3M40.0%
- 1Y40.0%
- YTD12.9%
Over the last 7 days, the Biotech industry has remained flat. The past year has been better, since the industry has gained 45% in that time. Looking forward, earnings are forecast to grow by 17% annually.
Industry Valuation and Performance
Has the New Zealand Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 25 Nov 2024 | NZ$113.7m | NZ$25.2m | -NZ$29,535,000.00 | n/a | -3.8x | 4.5x |
| Wed, 23 Oct 2024 | NZ$114.5m | NZ$25.2m | -NZ$29,535,000.00 | n/a | -3.9x | 4.5x |
| Fri, 20 Sep 2024 | NZ$131.5m | NZ$25.2m | -NZ$29,535,000.00 | n/a | -4.5x | 5.2x |
| Sun, 18 Aug 2024 | NZ$79.6m | NZ$25.2m | -NZ$29,535,000.00 | n/a | -2.7x | 3.2x |
| Tue, 16 Jul 2024 | NZ$68.2m | NZ$25.2m | -NZ$29,535,000.00 | n/a | -2.3x | 2.7x |
| Thu, 13 Jun 2024 | NZ$77.9m | NZ$25.2m | -NZ$29,535,000.00 | n/a | -2.6x | 3.1x |
| Sat, 11 May 2024 | NZ$75.5m | NZ$25.5m | -NZ$31,646,000.00 | n/a | -2.4x | 3x |
| Mon, 08 Apr 2024 | NZ$69.8m | NZ$25.5m | -NZ$31,646,000.00 | n/a | -2.2x | 2.7x |
| Wed, 06 Mar 2024 | NZ$69.0m | NZ$25.5m | -NZ$31,646,000.00 | n/a | -2.2x | 2.7x |
| Fri, 02 Feb 2024 | NZ$85.2m | NZ$25.5m | -NZ$31,646,000.00 | n/a | -2.7x | 3.3x |
| Sun, 31 Dec 2023 | NZ$94.9m | NZ$25.5m | -NZ$31,646,000.00 | n/a | -3x | 3.7x |
| Tue, 28 Nov 2023 | NZ$81.1m | NZ$25.5m | -NZ$31,646,000.00 | n/a | -2.6x | 3.2x |
| Thu, 26 Oct 2023 | NZ$81.1m | NZ$21.0m | -NZ$26,965,000.00 | n/a | -3x | 3.9x |
| Sat, 23 Sep 2023 | NZ$105.0m | NZ$21.0m | -NZ$26,965,000.00 | n/a | -3.9x | 5x |
| Mon, 21 Aug 2023 | NZ$105.3m | NZ$21.0m | -NZ$26,965,000.00 | n/a | -3.9x | 5x |
| Wed, 19 Jul 2023 | NZ$162.1m | NZ$21.0m | -NZ$26,965,000.00 | n/a | -6x | 7.7x |
| Fri, 16 Jun 2023 | NZ$79.4m | NZ$21.0m | -NZ$26,965,000.00 | n/a | -2.9x | 3.8x |
| Sun, 14 May 2023 | NZ$344.4m | NZ$16.5m | -NZ$21,374,000.00 | n/a | -16.1x | 20.9x |
| Tue, 11 Apr 2023 | NZ$328.2m | NZ$16.5m | -NZ$21,374,000.00 | n/a | -15.4x | 19.9x |
| Thu, 09 Mar 2023 | NZ$380.9m | NZ$16.5m | -NZ$21,374,000.00 | n/a | -17.8x | 23.1x |
| Sat, 04 Feb 2023 | NZ$405.2m | NZ$16.5m | -NZ$21,374,000.00 | n/a | -19x | 24.6x |
| Mon, 02 Jan 2023 | NZ$405.2m | NZ$16.5m | -NZ$21,374,000.00 | n/a | -19x | 24.6x |
| Wed, 30 Nov 2022 | NZ$397.0m | NZ$16.5m | -NZ$21,374,000.00 | n/a | -18.6x | 24.1x |
| Fri, 28 Oct 2022 | NZ$344.3m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -17.4x | 26.2x |
| Sun, 25 Sep 2022 | NZ$388.9m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -19.7x | 29.6x |
| Tue, 23 Aug 2022 | NZ$380.8m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -19.2x | 29x |
| Thu, 21 Jul 2022 | NZ$615.7m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -31.1x | 46.9x |
| Sat, 18 Jun 2022 | NZ$575.2m | NZ$13.1m | -NZ$19,788,000.00 | n/a | -29.1x | 43.8x |
| Mon, 16 May 2022 | NZ$640.0m | NZ$11.5m | -NZ$16,115,000.00 | n/a | -39.7x | 55.6x |
| Wed, 13 Apr 2022 | NZ$753.4m | NZ$11.5m | -NZ$16,115,000.00 | n/a | -46.8x | 65.4x |
| Fri, 11 Mar 2022 | NZ$704.8m | NZ$11.5m | -NZ$16,115,000.00 | n/a | -43.7x | 61.2x |
| Sun, 06 Feb 2022 | NZ$899.1m | NZ$11.5m | -NZ$16,115,000.00 | n/a | -55.8x | 78.1x |
| Tue, 04 Jan 2022 | NZ$1.1b | NZ$11.5m | -NZ$16,115,000.00 | n/a | -66.8x | 93.5x |
| Thu, 02 Dec 2021 | NZ$995.6m | NZ$11.5m | -NZ$16,115,000.00 | n/a | -61.8x | 86.4x |
Price to Earnings Ratio
-61.8x
Current Industry PE
- There is only one company in the New Zealander Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 41% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the New Zealand Healthcare industry?
| NZ Market | 2.02% | |
| Healthcare | 3.61% | |
| Biotech | 12.00% | |
| Biotech | 12.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PEB Pacific Edge | NZ$0.14 | 17.5% +NZ$17.1m | 41.0% | PS4.5x |